Maxime Gualtieri
Research Subjects
Maxime Gualtieri has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
Jessica Houard
Nosopharm
9 shared publications- Alain Givaudan
DGIMI, Univ Montpellier, INRAE
7 shared publications Lucile Pantel
Nosopharm
7 shared publicationsEmilie Racine
Nosopharm, Nîmes, France
5 shared publications- Emilie Racine
Nosopharm
4 shared publications Marine Serri
Nosopharm, Nîmes, France
4 shared publications
Latest Publications
- Open Access
- 7 October 2026
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 70 (10)
N-terminal lysine as a critical determinant of odilorhabdin susceptibility to inactivation by the self-resistance acetyltransferase OatA
Odilorhabdins (ODLs) are a novel class of peptide antibiotics that inhibit bacterial translation by binding to the 30S ribosomal subunit. Xenorhabdus nematophila , an ODL-producing bacterium, encodes a highly specialized self-resistance acetyltransferase, OatA, that inactivates ODLs via primary amine modification. In this study, we investigated the structural determinants governing susceptibility of the natural compound NOSO-95C to OatA-mediated inactivation. Using an alanine-scanning library, we identified N -terminal lysine (Lys 1 ) as the key structural determinant of acetyltransferase susceptibility. Expression of oatA in E. coli increased the MIC of NOSO-95C by 64-fold due to rapid OatA-mediated acetylation. In contrast, analog 1 (Lys1→Ala) was no longer discriminated between Oat-A expressing and non-expressing strains, and remained 95.4% unacetylated after 4 h of incubation. Functional assays confirmed that analog 1 retains potent translation inhibition and antibacterial activity despite enzyme exposure. Furthermore, OatA failed to inactivate other amine-containing clinical antibiotics such as aminoglycosides, penicillin, or polymyxins. These results indicate that the side chain of N -terminal lysine is essential for efficient OatA-mediated acetylation of ODLs. Moreover, this single residue can be modified to enable ODLs to evade enzymatic inactivation while preserving their primary mechanism of action. This work provides a clear structure-activity framework for the rational design of next-generation ODLs with enhanced stability against OatA-mediated enzymatic modification.
- 7 October 2026
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 70 (10)
Open AccessN-terminal lysine as a critical determinant of odilorhabdin susceptibility to inactivation by the self-resistance acetyltransferase OatA
Odilorhabdins (ODLs) are a novel class of peptide antibiotics that inhibit bacterial translation by binding to the 30S ribosomal subunit. Xenorhabdus nematophila , an ODL-producing bacterium, encodes a highly specialized self-resistance acetyltransferase, OatA, that inactivates ODLs via primary amine modification. In this study, we investigated the structural determinants governing susceptibility of the natural compound NOSO-95C to OatA-mediated inactivation. Using an alanine-scanning library, we identified N -terminal lysine (Lys 1 ) as the key structural determinant of acetyltransferase susceptibility. Expression of oatA in E. coli increased the MIC of NOSO-95C by 64-fold due to rapid OatA-mediated acetylation. In contrast, analog 1 (Lys1→Ala) was no longer discriminated between Oat-A expressing and non-expressing strains, and remained 95.4% unacetylated after 4 h of incubation. Functional assays confirmed that analog 1 retains potent translation inhibition and antibacterial activity despite enzyme exposure. Furthermore, OatA failed to inactivate other amine-containing clinical antibiotics such as aminoglycosides, penicillin, or polymyxins. These results indicate that the side chain of N -terminal lysine is essential for efficient OatA-mediated acetylation of ODLs. Moreover, this single residue can be modified to enable ODLs to evade enzymatic inactivation while preserving their primary mechanism of action. This work provides a clear structure-activity framework for the rational design of next-generation ODLs with enhanced stability against OatA-mediated enzymatic modification.
- Open Access
- 7 July 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (7) , e0046626
MexXY-OprM efflux pump mediates resistance to odilorhabdins in Pseudomonas aeruginosa
The urgent need for new antibiotic classes to treat infections caused by multidrug-resistant gram-negative pathogens has driven interest in odilorhabdins (ODLs), a novel class of cationic antimicrobial peptides that target the bacterial ribosome. NOSO-502, the first clinical candidate in this family, exhibits potent activity against multidrug-resistant Enterobacteriaceae but is inactive against Pseudomonas aeruginosa isolates. This study investigates the intrinsic resistance of P. aeruginosa to NOSO-502 using the reference strain PAO1. Our data indicate that NOSO-502 induces overexpression of the MexXY-OprM efflux pump, which mediates drug extrusion from the periplasm and limits antibacterial activity. To further explore the role of MexXY-OprM, we evaluated NOSO-95C, the first purified ODL from natural origin. Unlike NOSO-502, NOSO-95C does not induce overexpression of MexXY-OprM at subinhibitory concentrations, resulting in measurable antibacterial activity against PAO1. However, NOSO-95C remains susceptible to MexXY-OprM-mediated efflux, as evidenced by its limited efficacy against strains that constitutively overexpress this pump. To better understand the structural basis of these differences, we investigated the relationship between ODL structures and the ability to induce mexXY expression. Our results demonstrate that both the amino acid at position 7 and the C -terminal region of the ODL scaffold are critical determinants of MexXY induction and efflux susceptibility. These findings offer valuable insights for the design of next-generation ODLs with improved efficacy against P. aeruginosa . IMPORTANCE: Pseudomonas aeruginosa is a major cause of hospital-acquired infections. Odilorhabdins (ODLs) are a novel class of ribosome-targeting antibiotics with promising activity against multidrug-resistant gram-negative bacteria. Unfortunately, their efficacy against P. aeruginosa remains limited. In this study, we identify the MexXY-OprM efflux pump as the primary determinant of intrinsic resistance of P. aeruginosa to ODLs. We show that the clinical candidate NOSO-502 strongly induces mexXY expression, resulting in active self-efflux and loss of antibacterial activity, whereas the natural ODL NOSO-95C displays reduced induction and partial activity. By combining microbiological, transcriptional, uptake, and structure-activity analyses, we demonstrate that specific structural patterns of ODLs govern both efflux susceptibility and efflux pump induction. These findings pave the way for the design of the next ODL generation with improved activity against P. aeruginosa .
- 7 July 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (7) , e0046626
Open AccessMexXY-OprM efflux pump mediates resistance to odilorhabdins in Pseudomonas aeruginosa
The urgent need for new antibiotic classes to treat infections caused by multidrug-resistant gram-negative pathogens has driven interest in odilorhabdins (ODLs), a novel class of cationic antimicrobial peptides that target the bacterial ribosome. NOSO-502, the first clinical candidate in this family, exhibits potent activity against multidrug-resistant Enterobacteriaceae but is inactive against Pseudomonas aeruginosa isolates. This study investigates the intrinsic resistance of P. aeruginosa to NOSO-502 using the reference strain PAO1. Our data indicate that NOSO-502 induces overexpression of the MexXY-OprM efflux pump, which mediates drug extrusion from the periplasm and limits antibacterial activity. To further explore the role of MexXY-OprM, we evaluated NOSO-95C, the first purified ODL from natural origin. Unlike NOSO-502, NOSO-95C does not induce overexpression of MexXY-OprM at subinhibitory concentrations, resulting in measurable antibacterial activity against PAO1. However, NOSO-95C remains susceptible to MexXY-OprM-mediated efflux, as evidenced by its limited efficacy against strains that constitutively overexpress this pump. To better understand the structural basis of these differences, we investigated the relationship between ODL structures and the ability to induce mexXY expression. Our results demonstrate that both the amino acid at position 7 and the C -terminal region of the ODL scaffold are critical determinants of MexXY induction and efflux susceptibility. These findings offer valuable insights for the design of next-generation ODLs with improved efficacy against P. aeruginosa . IMPORTANCE: Pseudomonas aeruginosa is a major cause of hospital-acquired infections. Odilorhabdins (ODLs) are a novel class of ribosome-targeting antibiotics with promising activity against multidrug-resistant gram-negative bacteria. Unfortunately, their efficacy against P. aeruginosa remains limited. In this study, we identify the MexXY-OprM efflux pump as the primary determinant of intrinsic resistance of P. aeruginosa to ODLs. We show that the clinical candidate NOSO-502 strongly induces mexXY expression, resulting in active self-efflux and loss of antibacterial activity, whereas the natural ODL NOSO-95C displays reduced induction and partial activity. By combining microbiological, transcriptional, uptake, and structure-activity analyses, we demonstrate that specific structural patterns of ODLs govern both efflux susceptibility and efflux pump induction. These findings pave the way for the design of the next ODL generation with improved activity against P. aeruginosa .
- Open Access
- 7 October 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (10) , e0110625
Global transcriptomics and targeted metabolite analysis reveal the involvement of the AcrAB efflux pump in physiological functions by exporting signaling molecules in Photorhabdus laumondii
In Gram-negative bacteria, resistance-nodulation-division (RND)-type efflux pumps, particularly AcrAB-TolC, play a critical role in mediating resistance to antimicrobial agents and toxic metabolites, contributing to multidrug resistance. Photorhabdus laumondii is an entomopathogenic bacterium that has garnered significant interest due to its production of bioactive specialized metabolites with anti-inflammatory, antimicrobial, and scavenger deterrent properties. In previous work, we demonstrated that AcrAB confers self-resistance to stilbenes in P. laumondii TT01. Here, we explore the pleiotropic effects of AcrAB in this bacterium. RNA sequencing of ∆ acrA compared to wild type revealed growth-phase-specific gene regulation, with stationary-phase cultures showing significant downregulation of genes involved in stilbene, fatty acid, and anthraquinone pigment biosynthesis, as well as genes related to cellular clumping and fimbrial pilin formation. Genes encoding putative LuxR regulators, type VI secretion systems, two-partner secretion systems, and contact-dependent growth inhibition systems were upregulated in ∆ acrA . Additionally, exponential-phase cultures revealed reduced expression of genes related to motility in ∆ acrA . The observed transcriptional changes were consistent with phenotypic assays, demonstrating that the ∆ acrA mutant had altered bioluminescence and defective orange pigmentation due to disrupted anthraquinone production. These findings confirm the role of stilbenes as signaling molecules involved in gene expression, thereby shaping these phenotypes. Furthermore, we showed that AcrAB contributes to swarming and swimming motilities independently of stilbenes. Collectively, these results highlight that disrupting acrAB causes transcriptional and metabolic dysregulation in P. laumondii , likely by impeding the export of key signaling molecules such as stilbenes, which may serve as a ligand for global transcriptional regulators. IMPORTANCE: Recent discoveries have highlighted Photorhabdus laumondii as a promising source of novel anti-infective compounds, including non-ribosomal peptides and polyketides. One key player in the self-resistance of this bacterium to stilbene derivatives is the AcrAB-TolC complex, which is also a well-known contributor to multidrug resistance. Here, we demonstrate the pleiotropic effects of the AcrAB efflux pump in P. laumondii TT01, impacting secondary metabolite biosynthesis, motility, and bioluminescence. These effects are evident at transcriptional, metabolic, and phenotypic levels and are likely mediated by the efflux of signaling molecules such as stilbenes. These findings shed light on the multifaceted roles of efflux pumps and open avenues to better explore the complexity of resistance-nodulation-division (RND) pump-mediated signaling pathways in bacteria, thereby aiding in combating multidrug-resistant infections.
- 7 October 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (10) , e0110625
Open AccessGlobal transcriptomics and targeted metabolite analysis reveal the involvement of the AcrAB efflux pump in physiological functions by exporting signaling molecules in Photorhabdus laumondii
In Gram-negative bacteria, resistance-nodulation-division (RND)-type efflux pumps, particularly AcrAB-TolC, play a critical role in mediating resistance to antimicrobial agents and toxic metabolites, contributing to multidrug resistance. Photorhabdus laumondii is an entomopathogenic bacterium that has garnered significant interest due to its production of bioactive specialized metabolites with anti-inflammatory, antimicrobial, and scavenger deterrent properties. In previous work, we demonstrated that AcrAB confers self-resistance to stilbenes in P. laumondii TT01. Here, we explore the pleiotropic effects of AcrAB in this bacterium. RNA sequencing of ∆ acrA compared to wild type revealed growth-phase-specific gene regulation, with stationary-phase cultures showing significant downregulation of genes involved in stilbene, fatty acid, and anthraquinone pigment biosynthesis, as well as genes related to cellular clumping and fimbrial pilin formation. Genes encoding putative LuxR regulators, type VI secretion systems, two-partner secretion systems, and contact-dependent growth inhibition systems were upregulated in ∆ acrA . Additionally, exponential-phase cultures revealed reduced expression of genes related to motility in ∆ acrA . The observed transcriptional changes were consistent with phenotypic assays, demonstrating that the ∆ acrA mutant had altered bioluminescence and defective orange pigmentation due to disrupted anthraquinone production. These findings confirm the role of stilbenes as signaling molecules involved in gene expression, thereby shaping these phenotypes. Furthermore, we showed that AcrAB contributes to swarming and swimming motilities independently of stilbenes. Collectively, these results highlight that disrupting acrAB causes transcriptional and metabolic dysregulation in P. laumondii , likely by impeding the export of key signaling molecules such as stilbenes, which may serve as a ligand for global transcriptional regulators. IMPORTANCE: Recent discoveries have highlighted Photorhabdus laumondii as a promising source of novel anti-infective compounds, including non-ribosomal peptides and polyketides. One key player in the self-resistance of this bacterium to stilbene derivatives is the AcrAB-TolC complex, which is also a well-known contributor to multidrug resistance. Here, we demonstrate the pleiotropic effects of the AcrAB efflux pump in P. laumondii TT01, impacting secondary metabolite biosynthesis, motility, and bioluminescence. These effects are evident at transcriptional, metabolic, and phenotypic levels and are likely mediated by the efflux of signaling molecules such as stilbenes. These findings shed light on the multifaceted roles of efflux pumps and open avenues to better explore the complexity of resistance-nodulation-division (RND) pump-mediated signaling pathways in bacteria, thereby aiding in combating multidrug-resistant infections.
- Open Access
Global Transcriptomics and Targeted Metabolite Analysis Reveal the Involvement of the AcrAB Efflux Pump in Physiological Functions by Exporting Signaling Molecules in Photorhabdus laumondii
In Gram-negative bacteria, resistance-nodulation-division-type efflux pumps, particularly AcrAB-TolC, play a critical role in mediating resistance to antimicrobial agents and toxic metabolites, contributing to multidrug resistance. Photorhabdus laumondii is an entomopathogenic bacterium that has garnered significant interest due to its production of bioactive specialized metabolites with anti-inflammatory, antimicrobial, and scavenger deterrents properties. In previous work, we demonstrated that AcrAB confers self-resistance to stilbenes in P. laumondii TT01. Here, we explore the pleiotropic effects of AcrAB in this bacterium. RNA sequencing of Δ acrA compared to wild-type revealed growth-phase-specific gene regulation, with stationary-phase cultures showing significant downregulation of genes involved in stilbenes, fatty acid, and anthraquinone pigment biosynthesis, as well as genes related to cellular clumping and fimbrial pilin formation. Genes encoding putative LuxR regulators, type VI secretion systems, two-partner secretion systems, and contact dependent growth inhibition systems were upregulated in Δ acrA . Additionally, exponential-phase cultures revealed reduced expression of genes related to motility in Δ acrA . The observed transcriptional changes were consistent with phenotypic assays, demonstrating that the Δ acrA mutant had altered bioluminescence and defective orange pigmentation due to disrupted anthraquinone production. These findings confirm the role of stilbenes as signaling molecules involved in gene expression, thereby shaping these phenotypes. Furthermore, we showed that AcrAB contributes to swarming and swimming motilities independently of stilbenes. Collectively, these results highlight that disrupting acrAB causes transcriptional and metabolic dysregulation in P. laumondii , likely by impeding the export of key signaling molecules such as stilbenes, which may serve as a ligand for global transcriptional regulators. Importance: Recent discoveries have highlighted Photorhabdus laumondii as a promising source of novel anti-infective compounds, including non-ribosomal peptides and polyketides. One key player in the self-resistance of this bacterium to stilbene derivatives is the AcrAB-TolC complex, which is also a well-known contributor to multidrug-resistance. Here, we demonstrate the pleiotropic effects of the AcrAB efflux pump in P. laumondii TT01, impacting secondary metabolite biosynthesis, motility, and bioluminescence. These effects are evident at transcriptional, metabolic, and phenotypic levels and are likely mediated by the efflux of signaling molecules such as stilbenes. These findings shed light on the multifaceted roles of efflux pumps and open avenues to better explore the complexity of RND pump-mediated signaling pathways in bacteria, thereby aiding combat multidrug resistant infections.
Open AccessGlobal Transcriptomics and Targeted Metabolite Analysis Reveal the Involvement of the AcrAB Efflux Pump in Physiological Functions by Exporting Signaling Molecules in Photorhabdus laumondii
In Gram-negative bacteria, resistance-nodulation-division-type efflux pumps, particularly AcrAB-TolC, play a critical role in mediating resistance to antimicrobial agents and toxic metabolites, contributing to multidrug resistance. Photorhabdus laumondii is an entomopathogenic bacterium that has garnered significant interest due to its production of bioactive specialized metabolites with anti-inflammatory, antimicrobial, and scavenger deterrents properties. In previous work, we demonstrated that AcrAB confers self-resistance to stilbenes in P. laumondii TT01. Here, we explore the pleiotropic effects of AcrAB in this bacterium. RNA sequencing of Δ acrA compared to wild-type revealed growth-phase-specific gene regulation, with stationary-phase cultures showing significant downregulation of genes involved in stilbenes, fatty acid, and anthraquinone pigment biosynthesis, as well as genes related to cellular clumping and fimbrial pilin formation. Genes encoding putative LuxR regulators, type VI secretion systems, two-partner secretion systems, and contact dependent growth inhibition systems were upregulated in Δ acrA . Additionally, exponential-phase cultures revealed reduced expression of genes related to motility in Δ acrA . The observed transcriptional changes were consistent with phenotypic assays, demonstrating that the Δ acrA mutant had altered bioluminescence and defective orange pigmentation due to disrupted anthraquinone production. These findings confirm the role of stilbenes as signaling molecules involved in gene expression, thereby shaping these phenotypes. Furthermore, we showed that AcrAB contributes to swarming and swimming motilities independently of stilbenes. Collectively, these results highlight that disrupting acrAB causes transcriptional and metabolic dysregulation in P. laumondii , likely by impeding the export of key signaling molecules such as stilbenes, which may serve as a ligand for global transcriptional regulators. Importance: Recent discoveries have highlighted Photorhabdus laumondii as a promising source of novel anti-infective compounds, including non-ribosomal peptides and polyketides. One key player in the self-resistance of this bacterium to stilbene derivatives is the AcrAB-TolC complex, which is also a well-known contributor to multidrug-resistance. Here, we demonstrate the pleiotropic effects of the AcrAB efflux pump in P. laumondii TT01, impacting secondary metabolite biosynthesis, motility, and bioluminescence. These effects are evident at transcriptional, metabolic, and phenotypic levels and are likely mediated by the efflux of signaling molecules such as stilbenes. These findings shed light on the multifaceted roles of efflux pumps and open avenues to better explore the complexity of RND pump-mediated signaling pathways in bacteria, thereby aiding combat multidrug resistant infections.
- 15 May 2023
- Published by Elsevier in Research in Microbiology
- Vol. 174 (7) , 104081
The AcrAB efflux pump confers self-resistance to stilbenes in Photorhabdus laumondii
- 15 May 2023
- Published by Elsevier in Research in Microbiology
- Vol. 174 (7) , 104081
The AcrAB efflux pump confers self-resistance to stilbenes in Photorhabdus laumondii
- Open Access
- 15 November 2022
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 66 (11) , e0077622
Exploring Cluster-Dependent Antibacterial Activities and Resistance Pathways of NOSO-502 and Colistin against Enterobacter cloacae Complex Species
The Enterobacter cloacae complex (ECC) is a group of diverse environmental and clinically relevant bacterial species associated with a variety of infections in humans. ECC have emerged as one of the leading causes of nosocomial infections worldwide.
- 15 November 2022
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 66 (11) , e0077622
Open AccessExploring Cluster-Dependent Antibacterial Activities and Resistance Pathways of NOSO-502 and Colistin against Enterobacter cloacae Complex Species
The Enterobacter cloacae complex (ECC) is a group of diverse environmental and clinically relevant bacterial species associated with a variety of infections in humans. ECC have emerged as one of the leading causes of nosocomial infections worldwide.
- Open Access
Type Strains of Entomopathogenic Nematode-Symbiotic Bacterium Species, Xenorhabdus szentirmaii (EMC) and X. budapestensis (EMA), Are Exceptional Sources of Non-Ribosomal Templated, Large-Target-Spectral, Thermotolerant-Antimicrobial Peptides (by Both), and Iodinin (by EMC)
Antimicrobial multidrug resistance (MDR) is a global challenge, not only for public health, but also for sustainable agriculture. Antibiotics used in humans should be ruled out for use in veterinary or agricultural settings. Applying antimicrobial peptide (AMP) molecules, produced by soil-born organisms for protecting (soil-born) plants, seems a preferable alternative. The natural role of peptide-antimicrobials, produced by the prokaryotic partner of entomopathogenic-nematode/bacterium (EPN/EPB) symbiotic associations, is to sustain monoxenic conditions for the EPB in the gut of the semi-anabiotic infective dauer juvenile (IJ) EPN. They keep pathobiome conditions balanced for the EPN/EPB complex in polyxenic (soil, vanquished insect cadaver) niches. Xenorhabdus szentirmaii DSM16338(T) (EMC), and X. budapestensis DSM16342(T) (EMA), are the respective natural symbionts of EPN species Steinernema rarum and S. bicornutum. We identified and characterized both of these 15 years ago. The functional annotation of the draft genome of EMC revealed 71 genes encoding non-ribosomal peptide synthases, and polyketide synthases. The large spatial Xenorhabdus AMP (fabclavine), was discovered in EMA, and its biosynthetic pathway in EMC. The AMPs produced by EMA and EMC are promising candidates for controlling MDR prokaryotic and eukaryotic pathogens (bacteria, oomycetes, fungi, protozoa). EMC releases large quantity of iodinin (1,6-dihydroxyphenazine 5,10-dioxide) in a water-soluble form into the media, where it condenses to form spectacular water-insoluble, macroscopic crystals. This review evaluates the scientific impact of international research on EMA and EMC.
Open AccessType Strains of Entomopathogenic Nematode-Symbiotic Bacterium Species, Xenorhabdus szentirmaii (EMC) and X. budapestensis (EMA), Are Exceptional Sources of Non-Ribosomal Templated, Large-Target-Spectral, Thermotolerant-Antimicrobial Peptides (by Both), and Iodinin (by EMC)
Antimicrobial multidrug resistance (MDR) is a global challenge, not only for public health, but also for sustainable agriculture. Antibiotics used in humans should be ruled out for use in veterinary or agricultural settings. Applying antimicrobial peptide (AMP) molecules, produced by soil-born organisms for protecting (soil-born) plants, seems a preferable alternative. The natural role of peptide-antimicrobials, produced by the prokaryotic partner of entomopathogenic-nematode/bacterium (EPN/EPB) symbiotic associations, is to sustain monoxenic conditions for the EPB in the gut of the semi-anabiotic infective dauer juvenile (IJ) EPN. They keep pathobiome conditions balanced for the EPN/EPB complex in polyxenic (soil, vanquished insect cadaver) niches. Xenorhabdus szentirmaii DSM16338(T) (EMC), and X. budapestensis DSM16342(T) (EMA), are the respective natural symbionts of EPN species Steinernema rarum and S. bicornutum. We identified and characterized both of these 15 years ago. The functional annotation of the draft genome of EMC revealed 71 genes encoding non-ribosomal peptide synthases, and polyketide synthases. The large spatial Xenorhabdus AMP (fabclavine), was discovered in EMA, and its biosynthetic pathway in EMC. The AMPs produced by EMA and EMC are promising candidates for controlling MDR prokaryotic and eukaryotic pathogens (bacteria, oomycetes, fungi, protozoa). EMC releases large quantity of iodinin (1,6-dihydroxyphenazine 5,10-dioxide) in a water-soluble form into the media, where it condenses to form spectacular water-insoluble, macroscopic crystals. This review evaluates the scientific impact of international research on EMA and EMC.
- Open Access
- 22 February 2022
- Published by American Society for Microbiology in mBio
- Vol. 13 (1) , e0282621
The Odilorhabdin Antibiotic Biosynthetic Cluster and Acetyltransferase Self-Resistance Locus Are Niche and Species Specific
Odilorhabdins (ODLs) constitute a novel antibiotic family with promising properties for treating problematic multidrug-resistant Gram-negative bacterial infections. ODLs are 10-mer linear cationic peptides inhibiting bacterial translation by binding to the small subunit of the ribosome.
- 22 February 2022
- Published by American Society for Microbiology in mBio
- Vol. 13 (1) , e0282621
Open AccessThe Odilorhabdin Antibiotic Biosynthetic Cluster and Acetyltransferase Self-Resistance Locus Are Niche and Species Specific
Odilorhabdins (ODLs) constitute a novel antibiotic family with promising properties for treating problematic multidrug-resistant Gram-negative bacterial infections. ODLs are 10-mer linear cationic peptides inhibiting bacterial translation by binding to the small subunit of the ribosome.
- 19 April 2021
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 65 (5)
Missense Mutations in the CrrB Protein Mediate Odilorhabdin Derivative Resistance in Klebsiella pneumoniae
NOSO-502 is a preclinical antibiotic candidate of the odilorhabdin class. This compound exhibits activity against Enterobacteriaceae pathogens, including carbapenemase-producing bacteria and most of the colistin (CST)-resistant strains.
- 19 April 2021
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 65 (5)
Missense Mutations in the CrrB Protein Mediate Odilorhabdin Derivative Resistance in Klebsiella pneumoniae
NOSO-502 is a preclinical antibiotic candidate of the odilorhabdin class. This compound exhibits activity against Enterobacteriaceae pathogens, including carbapenemase-producing bacteria and most of the colistin (CST)-resistant strains.
- Open Access
- 18 December 2019
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 10, 2893
From Worms to Drug Candidate: The Story of Odilorhabdins, a New Class of Antimicrobial Agents
A major issue currently facing medicine is antibiotic resistance. No new class of antibiotics for the treatment of Gram-negative infections has been introduced in more than 40 years. We screened a collection of Xenorhabdus and Photorhabdus strains in the quest to discover new structures that are active against the most problematic multidrug-resistant bacteria. These species are symbiotic bacteria of entomopathogenic nematodes and their life cycle, the richness of the bacteria’s genome in non-ribosomal peptide synthetase (NRPS) and polyketide synthase (PKS) genes, and their propensity to produce secondary metabolites with a large diversity of chemical structures make them a good starting point to begin an ambitious drug discovery program. Odilorhabdins (ODLs), a novel antibacterial class, were identified from this campaign. These compounds inhibit bacterial translation by binding to the small ribosomal subunit at a site not exploited by current antibiotics. Following the development of the total synthesis of this family of peptides, a medicinal chemistry program was started to optimize their pharmacological properties. NOSO-502, the first ODL preclinical candidate was selected. This compound is currently under preclinical development for the treatment of multidrug-resistant Gram-negative infections in hospitalized patients.
- 18 December 2019
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 10, 2893
Open AccessFrom Worms to Drug Candidate: The Story of Odilorhabdins, a New Class of Antimicrobial Agents
A major issue currently facing medicine is antibiotic resistance. No new class of antibiotics for the treatment of Gram-negative infections has been introduced in more than 40 years. We screened a collection of Xenorhabdus and Photorhabdus strains in the quest to discover new structures that are active against the most problematic multidrug-resistant bacteria. These species are symbiotic bacteria of entomopathogenic nematodes and their life cycle, the richness of the bacteria’s genome in non-ribosomal peptide synthetase (NRPS) and polyketide synthase (PKS) genes, and their propensity to produce secondary metabolites with a large diversity of chemical structures make them a good starting point to begin an ambitious drug discovery program. Odilorhabdins (ODLs), a novel antibacterial class, were identified from this campaign. These compounds inhibit bacterial translation by binding to the small ribosomal subunit at a site not exploited by current antibiotics. Following the development of the total synthesis of this family of peptides, a medicinal chemistry program was started to optimize their pharmacological properties. NOSO-502, the first ODL preclinical candidate was selected. This compound is currently under preclinical development for the treatment of multidrug-resistant Gram-negative infections in hospitalized patients.